OligoProgressive Metastatic Disease Clinical Trials

11 clinical trials for OligoProgressive Metastatic Disease across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer — RECRUITING · PHASE2
• A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP) — RECRUITING · PHASE2
• Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma — RECRUITING · NA
• Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast) — RECRUITING · NA
• Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers — RECRUITING · NA
• Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer — RECRUITING · PHASE2
• Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC — RECRUITING · PHASE3
• The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC) — RECRUITING · PHASE2
• Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer — RECRUITING · PHASE3
• ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI) — NOT_YET_RECRUITING · PHASE2
• Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC） — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search